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Dr J. Goff (Albuquerque, NM). You had a fairly long delay
from the time that the patients were initially injured to the time
that they received their filter, the average was 8 days. As a former
military surgeon, I know that no injured soldier goes directly to
Walter Reed, they go someplace else first, usually through Land-
stuhl. Explain to us why those filters were either not placed in
country or were not placed where they first landed.
If your rate of recurrent subsequent thromboembolic events is
so low and your filters are being placed so late in the process, it begs
the question, why you’re placing somany and not taking them out.
Dr Johnson. Well, it’s an interesting point and it’s a great
question. And I know that VTE prophylaxis is very strongly
emphasized along every step of the evacuation chain as has been
discussed previously.
All of our patients were evaluated at Walter Reed with a
median delay of 8 days and received their filters here. There are a
certain number of patients that do get filters placed either far
forward in Iraq or at the Regional Medical Center in Landstuhl.
We didn’t include those patients in this particular analysis. But I
don’t have the data to tell you why some patients got them forward
and why some of them got them after 8 days.
In response to the second statement, the lack of subsequent
thromboembolic events, there may be a difference in the antico-
agulation profile of our patients. A lot of papers that are out there,
when they do quote anticoagulation that was given along with theposed to our patients where all of them were eventually anticoag-
ulated, a minority with a small delay.
I think this reflects the fact that our patients didn’t necessarily
have contraindications to anticoagulation per se, or a complication
while on anticoagulation. Rather, with multiple injuries requiring
frequent trips to the operating room every other day, frequent
interruptions in anticoagulation, multiple amputations, bulky casts
or dressings or external fixators that made traditional VTE prophy-
laxis untenable.
DrR. Zwolak (Lebanon, NH). It seems to me the question of
whether or not to retrieve a filter is still on the table. The question
is whether the risks of filter removal are any less than the risks of
leaving it in place. Does your data help us sort that out?
Dr Johnson. Well, our data doesn’t necessarily answer the
question of what should ultimately be done. It definitely tells us
that something needs to be reevaluated, for sure. The strength of
our paper is that in this trauma population, where in the civilian
world it would be very difficult to obtain 88% follow-up at 2-1/2
years, I think we’ve pretty much demonstrated and answered the
AAST’s question that even if you follow trauma patients out for a
long period of time, “retrievable” filters are not actually being
retrieved at a very high rate, and is the right thing really being
done.
I think the question needs to be asked: Are there independent
predictors that can tell when a permanent indication would call for
a permanent filter up front, or whether there is a role for interval
repositioning or some other type of management strategy?
